LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:LegoChem Biosciences Inc (141080) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8101
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:31
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LegoChem Biosciences Inc (LCB) is a biopharmaceutical company that develops next generation novel therapeutics. The company utilizes its proprietary medicinal drug discovery technology LegoChemistry and ADC platform technology ConjuAll. It manufactures drugs in the therapeutic areas of antibiotics, anticoagulants, anticancer and anti-inflammation. LCB’s services include joint and contract research, chemical library package, compound synthesis and sales, and screening services. Its screening services comprise metabolic stability, plasma stability, protein binding, and cell toxicity. LCB also offers compound synthesis and process development services. It conducts research programs through co-developments, joint researches, and global pharmaceutical companies. The company has operations in Seoul and Anseong, South Korea.LCB is headquartered in Daejeon, South Korea.

LegoChem Biosciences Inc (141080) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Novimmune and LegoChem Biosciences Enter into Research Agreement 11
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 12
LegoChem Biosciences Enters into Joint Venture Agreement with Geom Therapeutics 13
Y-Biologics Enters into Agreement with LegoChem Biosciences 14
LegoChem Biosciences Enters into Agreement with Theranyx 15
Seasun Biomaterials Enters into Agreement with LegoChem Biosciences 16
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 17
AstraZeneca Enters into Agreement with LegoChem for Antibiotic-Resistant Bacterial Infections 18
LegoChem Biosciences Enters into Research Agreement with Sanofi 19
Licensing Agreements 20
Geom Therapeutics Enters into Licensing Agreement with LegoChem Biosciences 20
Bridge Biotherapeutics Enters into Licensing Agreement with LegoChem Biosciences 21
Millennium Pharma Enters into Licensing Agreement with LegoChem Biosciences 22
LegoChem Biosciences Enters Licensing Agreement with RMX Biopharma 23
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 24
Equity Offering 25
LegoChem Biosciences Raises USD4.2 Million in Rights Offering 25
LegoChem Biosciences Raises USD21.8 Million in Private Placement of Shares 26
Debt Offering 27
LegoChem Biosciences Raises USD9.3 Million in Private Placement of Bonds 27
LegoChem Biosciences Inc – Key Competitors 28
LegoChem Biosciences Inc – Key Employees 29
LegoChem Biosciences Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Appendix 31
Methodology 31
About GlobalData 31
Contact Us 31
Disclaimer 31

List of Tables
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LegoChem Biosciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Novimmune and LegoChem Biosciences Enter into Research Agreement 11
Nordic Nanovector Enters into Partnership with LegoChem Biosciences 12
LegoChem Biosciences Enters into Joint Venture Agreement with Geom Therapeutics 13
Y-Biologics Enters into Agreement with LegoChem Biosciences 14
LegoChem Biosciences Enters into Agreement with Theranyx 15
Seasun Biomaterials Enters into Agreement with LegoChem Biosciences 16
LegoChem, Longthera and Medicilon Form Collaboration to Co-Develop LCB01-0699 17
AstraZeneca Enters into Agreement with LegoChem for Antibiotic-Resistant Bacterial Infections 18
LegoChem Biosciences Enters into Research Agreement with Sanofi 19
Geom Therapeutics Enters into Licensing Agreement with LegoChem Biosciences 20
Bridge Biotherapeutics Enters into Licensing Agreement with LegoChem Biosciences 21
Millennium Pharma Enters into Licensing Agreement with LegoChem Biosciences 22
LegoChem Biosciences Enters Licensing Agreement with RMX Biopharma 23
Shanghai Fosun Pharma Enters into Licensing Agreement with LegoChem Biosciences 24
LegoChem Biosciences Raises USD4.2 Million in Rights Offering 25
LegoChem Biosciences Raises USD21.8 Million in Private Placement of Shares 26
LegoChem Biosciences Raises USD9.3 Million in Private Placement of Bonds 27
LegoChem Biosciences Inc, Key Competitors 28
LegoChem Biosciences Inc, Key Employees 29
LegoChem Biosciences Inc, Other Locations 30

List of Figures
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
LegoChem Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[LegoChem Biosciences Inc (141080):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • VQ OrthoCare:企業の戦略的SWOT分析
    VQ OrthoCare - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Ensign Energy Services Inc (ESI):企業の財務・戦略的SWOT分析
    Summary Ensign Energy Services Inc (Ensign Energy) is an oil and gas company that offers oilfield services. The company’s services include directional drilling, horizontal drilling, well servicing and testing services. It provides well completions and recompletions, abandonment of redundant wells, s …
  • Lonestar Resources US Inc (LONE):石油・ガス:M&Aディール及び事業提携情報
    Summary Lonestar Resources US Inc (Lonestar) is an independent oil and gas company that focuses on acquisition, exploration, development and production of oil and natural gas resources. Lonestar holds majority of the working interests in its properties and manages activities related to designing and …
  • Oragenics Inc (OGEN):企業の財務・戦略的SWOT分析
    Oragenics Inc (OGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • HDFC Standard Life Insurance Company Limited:企業のM&A・事業提携・投資動向
    HDFC Standard Life Insurance Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HDFC Standard Life Insurance Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Asahi Kasei Pharma Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The company's portfolio encompasses prescription drugs, diagnostic reagents, and enzymes for diagnostic reagents. Its prescr …
  • Lake Country Power:企業の戦略的SWOT分析
    Lake Country Power - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Central Glass Co Ltd (4044):企業の財務・戦略的SWOT分析
    Central Glass Co Ltd (4044) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Lung Biotechnology PBC:製薬・医療:M&Aディール及び事業提携情報
    Summary Lung Biotechnology PBC (LBI), formerly Lung Biotechnology Inc, is a subsidiary of United Therapeutics Corp, is a biotechnology company that develops and commercializes new therapies for the treatment of PAH and other fatal lung diseases. The company provides product such as Adcirca and Tyvas …
  • ADVA Optical Networking SE (ADV):企業の財務・戦略的SWOT分析
    ADVA Optical Networking SE (ADV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Betta Pharmaceuticals Co Ltd (300558):製薬・医療:M&Aディール及び事業提携情報
    Summary Betta Pharmaceuticals Co Ltd (Betta Pharma) is a pharmaceutical company that researches, develops, manufactures and markets drugs for the treatment of cancer, cardiovascular diseases and diabetes. The company offers icotinib hydrochloride, an orally administered small-molecule, reversible ty …
  • Alliant Energy Corporation (LNT)-エネルギー分野:企業M&A・提携分析
    Summary Alliant Energy Corporation (Alliant Energy) is an energy utility holding company. Through subsidiaries, it carries out generation and distribution of electricity and distribution and transportation of natural gas. The company operates through Interstate Power and Light Company (IPL) and Wisc …
  • Army and Air Force Exchange Service:戦略・SWOT・企業財務分析
    Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report Summary Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Delek Group Ltd:企業のM&A・事業提携・投資動向
    Delek Group Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Delek Group Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Snyder’s-Lance Inc:企業の戦略的SWOT分析
    Snyder's-Lance Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Aernnova Aerospace, S.A.:企業の戦略・SWOT・財務情報
    Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report Summary Aernnova Aerospace, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Equinox Energy Capital Ltd:電力:M&Aディール及び事業提携情報
    Summary Equinox Energy Capital Ltd (Equinox) is an investment management firm that invests in wind and renewable energy assets. The firm spans its expertise in permitting, construction and asset management. It acquires PV plants which have existing project finance, lease or mortgage financing. Equin …
  • Ligand Pharmaceuticals Inc (LGND):製薬・医療:M&Aディール及び事業提携情報
    Summary Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company employs research technologies including nuclear receptor assays, formulation science, high throughput computer screening, antibody discovery technologies an …
  • Calian Group Ltd (CGY):企業の財務・戦略的SWOT分析
    Summary Calian Group Ltd (CTL), formerly Calian Technologies Ltd, is a diversified company that offers professional services in the areas of health, training, information technology, engineering and manufacturing. The company’s health division offers occupational health and other clinical services s …
  • Lennox International Inc.:企業の戦略・SWOT・財務情報
    Lennox International Inc. - Strategy, SWOT and Corporate Finance Report Summary Lennox International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆